| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.35 Billion | USD 8.91 Billion | 14.26% | 2024 |
FrequentlyAsked Questions
The global glycobiology/glycomics market is expected to grow due to growing applications in cancer and infectious disease studies, increasing research in drug discovery and biomarker development, advancements in glycan analysis technologies, and rising investments in pharmaceutical and biotechnology sectors.
According to a study, the global glycobiology/glycomics market size was worth around USD 2.35 Billion in 2024 and is expected to reach USD 8.91 Billion by 2034.
The global glycobiology/glycomics market is expected to grow at a CAGR of 14.26% during the forecast period.
North America is expected to dominate the glycobiology/glycomics market over the forecast period.
Leading players in the global glycobiology/glycomics market include Agilent Technologies, Waters Corporation, Lectenz Bio, Takara Bio, Thermo Fisher Scientific, Merck KGaA, New England Biolabs, ProZyme, Shimadzu Corporation, and S Bio., among others.
The report explores crucial aspects of the glycobiology/glycomics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients